Trend and risk factors of low birth weight and macrosomia in south China, 2005-2017: A retrospective observational study by Rao, J et al.
1ScIentIfIc REPORTS |  (2018) 8:3393  | DOI:10.1038/s41598-018-21771-6
www.nature.com/scientificreports
Trend and risk factors of low birth 
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The percentages of low birth weight (LBW) increased from 7.7% in 2005 to 11.3% in 2011 and declined 
to 8.1% in 2017. For very low birth weight (VLBW) individuals, the proportion declined −1.0% annually, 
from 2.5% in 2005 to 1.4% in 2017. Among moderately low birth weight (MLBW) individuals, the 
proportion first increased 12.8% annually, from 5.0% in 2005 to 9.3% in 2011, and then declined −3.8% 
annually, from 9.4% in 2011 to 7.0% in 2017. The percentages of macrosomia monotone decreased 
from 4.0% in 2005 to 2.5% in 2017, an annual decline of −4.0%. Multiple regression analyses showed 
that boys, maternal age, hypertensive disorders complicating pregnancy (HDCP), and diabetes were 
significant risk factors for LBW. Boys, maternal age, gestational age, HDCP, diabetes, and maternal BMI 
were significant risk factors for macrosomia. Although the relevant figures declined slightly in our study, 
it is likely that LBW and macrosomia will remain a major public health issue over the next few years in 
China. More research aimed at control and prevention of these risk factors for LBW and macrosomia and 
their detrimental outcome in the mother and perinatal child should be performed in China.
Low birth weight (LBW, <2500 g) is a most important factor of neonatal mortality and a major determinant 
of postnatal infant mortality, as well as morbidity in infancy and in older childhood1. Studies have shown that 
LBW infants die 40 times as much as normal weight infants, and LBW infants are many times more likely to end 
up with long-term handicapping conditions2. Children with LBW increased over the past two decades in many 
countries3–6. The prevalence of LBW is estimated to be 19% in developing countries and 5% to 7% in developed 
countries. According to Report of National Health Services Survey of China, the proportion of low birth weight 
has a ratio of 2.7% in 2006, and continuously increased with the scale-up of cities. Another research7 including 
39 hospital in 14 different provinces in China reported the incidence of LBW in mainland China was 6.1%. The 
risk factors for LBW, such as older maternal age, anemia, hypertension, and poor nutritional status, are widely 
reported in recent studies2,3,8,9.
Macrosomia refers to the body weight reaching or exceeding 4000 g, which can increase the risks of a poor 
pregnancy outcome in mothers and newborns10,11. Macrosomia are associated with increased risk of cesarean 
delivery, abnormal hemorrhage, shoulder dystocia, and post-term pregnancy, as well as keep the babies at a risk 
of perinatal asphyxia, fracture, cerebral hemorrhage even death12,13. Besides, studies have shown that there is a 
higher risk of developing obesity and metabolic disorders of macrosomia infants14. The proportion of macroso-
mia increased over the past thirty years in many countries15–18, with frequency ranging from 0.5% to 14.9% in 
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Asia, Africa and Latin America10. In particular, the number in China noted an increased from 6.0% in 1994 to 
7.8% in 200515. There is an increase of 15–25% reported in the past three decades mainly due to an increase of 
maternal obesity and diabetes19. It is strong evidence to show that male, older maternal age, maternal diabetes, 
gestational body-mass index (BMI) and higher parity were significantly associated with increased odds for mac-
rosomia in all regions10,20.
There are many studies focus on the incidence and risk factors of low birth weight and macrosomia, but little 
data on their long-term trends and their continuous observations in China. Besides, the etiology of low birth 
weight and macrosomia cannot be thoroughly explained by current researchs, so more observational studies 
are necessary. The purpose of our study was to examine the secular trend of LBW and macrosomia in Foshan, a 
city located in the south China, and explored relevant factors associated with LBW and macrosomia, to provide 
valuable information to reduce maternal and neonatal morbidity and mortality due to LBW and macrosomia.
Results
Characteristics of study population. The entire study population consisted of 102,526 individuals with 
a mean age ± SD of 28.3 ± 4.8 y. 25 to 29 year olds had the highest proportion of all individuals, reaching 43.2%, 
followed by 30 to 34 years (24.1%) and 20 to 24 years (20.0%). 61.7% of the study population were primiparae. The 
vast majority (98.6%) were Han Chinese. Clinical characteristics of the study population are described in Table 1.
Trends in incidence of weight subgroups. Among VLBW individuals, the proportion of which declined 
by −1.0% annually (95% CI, −2.6% to 0.5%), from 2.5% in 2005 to 1.4% in 2017. Among MLBW individuals, the 
proportion of which increased by 12.8% annually (95% CI, 8.5% to 17.3%), from 5.0% in 2005 to 9.3% in 2011, 
and declined by −3.8% annually (95% CI, −5.5% to −2.0%), from 9.4% in 2011 to 7.0% in 2017. The proportion 
of normal neonatal weight remained relatively stable, ranged 85.0% to 89.3%, then declined by −0.5% annually 
(95% CI: −0.7 to −0.3) during 2005 to 2011 and increased by 0.6% (95% CI: 0.3 to 0.8) annually during 2011 to 
2017. The proportion of macrosomia has declined from 4.1% to 2.5%, among which declined by −4.0% annually 
(95% CI: −5.5 to 2.5) during this period (Fig. 1).
Trends in average weight of weight subgroups. The proportion of VLBW, MLBW, normal and macro-
somia was 1.8%, 7.6%, 87.5% and 3.1% in the total population, respectively. The mean neonatal weight for VLBW, 
MLBW, normal and macrosomia was 1184 (SD:201), 2142 (SD:267), 3182 (SD:342) and 4198 (SD:447) grams, 
respectively (Table 2).
The mean weight of VLBW group in the whole population between 2005 and 2017 was 1243 grams (95% CI 
1108 to 1377) and 1209 grams (95% CI 984 to 1434).The mean weight of MLBW group between 2005 to 2017 has 
slightly increased from 2110 grams (95% CI 1842 to 2378) to 2136 grams (95% CI 1853 to 2419). The mean weight 
of Normal group between 2005 and 2017 was 3192 grams (95% CI 2848 to 3536) and 3210 grams (95% CI 2870 
to 3549). The mean weight of macrosomia group between 2005 and 2017 was 4176 grams (95% CI 3933 to 4419) 
and 4353 grams (95% CI 4021 to 4284) (Fig. 2).
From 2005 to 2017, there was a significant decrease in VLBW and macrosomia, with RR of 0.70 (95% CI: 
0.47 to 1.03) and 0.62 (95% CI: 0.47 to 0.83) in 2017 respectively, reference to 2005 (RR = 1), after adjusted for 
maternal age, parity and gestational age. The relative risk of MLBW rose rapidly at first during 2005 to 2010, with 
a peaked in 2010 (RR = 1.71, 95% CI: 1.45 to 2.02), and then declined slowly during 2010 to 2017 (RR = 1.18, 95% 
CI: 0.96 to 1.45). The RR value of normal weight infants dropped first and then increased, and the RR values were 
slightly increased in 2017 (RR = 1.12, 95% CI: 0.95 to 1.31), comparing with 2005 (Fig. 3).
Characteristic N (%) Characteristic N (%)
Live births, n, (%) 102526(100.0) Gestational age distribution, n (%)
Sex <37 wk 9294(10.6)
 Boys 54759(52.5) Apgar score at 5 minutes
Mean age ± SD, years 28.3 ± 4.8 <7 2896(2.7)
Age, n (%) 7–10 104363(97.3)
 <20 y 1459(1.4) BMI
 20–24 y 21483(20.0) <25 44087(44.3)
 25–29 y 46316(43.2) 25 to 30 46376(46.6)
 30–34 y 25869(24.1) ≥30 9056(9.1)
 >35 y 12113(11.3) HDCP
Nationality No 99215(96.3)
 Han Chinese 101,090(98.6) Yes 3812(3.7)
 Other 1435(1.4) Diabetes
Parity No 91890(90.0)
 0 64456(61.7) Yes 10210(10.0)
 1 34684(33.2) Mode of delivery
 2 4762(4.6) Vaginal 54625(61.7)
 ≥3 594(0.6) Cesarean section 45329(45.3)
Table 1. Characteristics of patients between 2005 and 2017.
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Multiple regression analysis. Boys (OR = 1.17, 95% CI: 1.08–1.26, p < 0.001), maternal age 20 to 24 years 
(OR = 1.19, 95% CI: 1.57–2.67, p < 0.001), maternal age 25 to 29 years (OR = 2.78, 95% CI: 2.14–3.61, p < 0.001), 
maternal age 30 to 34 years (OR = 2.63, 95% CI: 2.01–3.45, p < 0.001), maternal age >35 years (OR = 1.85, 95% 
CI: 1.35–2.46, p < 0.001), HDCP (OR = 5.92, 95% CI: 5.35–6.55, p < 0.001), diabetes (OR = 1.38, 95% CI: 1.26 to 
1.50, p < 0.001) were significant risk factors for LBW in the multiple logistic regression model.
Boys (OR = 1.91, 95% CI: 1.71–2.14, p < 0.001), maternal age 30 to 34 years (OR = 2.29, 95% CI: 1.17–4.47, 
p < 0.001), maternal age >35 years (OR = 2.44, 95% CI: 1.23–4.82, p < 0.001), HDCP (OR = 1.31, 95% CI: 1.02–
1.68, p < 0.001), diabetes (OR = 1.58, 95% CI: 1.36 to 1.83, p < 0.001), gestational age during 37 to 41 weeks 
(OR = 6.64, 95% CI: 5.21 to 8.44, p < 0.001), gestational age ≥42 weeks (OR = 20.45, 95% CI: 7.63 to 54.78, 
p < 0.001), BMI 25 to 30 (OR = 3.22, 95% CI: 2.69 to 3.84, p < 0.001), BMI > 30 (OR = 9.62, 95% CI: 7.91 to 11.72, 
p < 0.001) were significant risk factors for macrosomia in the multiple logistic regression model (Table 3).
Discussion
Many studies have focused on the incidence and risk factors of LBW and macrosomia, but there is little data 
on the long-term trends and ongoing observations in China. In this study, we determined the proportion of 
LBW and macrosomia in Foshan during 2005 to 2017, and identified the independent risk factors of LBW and 
Figure 1. Annual Percent Change (APC) by birth weight subgroups in Foshan during 2005 to 2017. Lines 
were fitted according to the Joinpoint Regression Program (National Cancer Institute), version 4.4.0.0, which 
uses permutation analysis to fit a series of straight lines on a logarithmic scale to observed rates, indicated by 
circles; up to 3 joinpoints (4 line segments) were allowed. aIndicates that the Annual Percent Change (APC) is 
significant different from zero at the alpha = 0.05 level.
All 2005 to 2011 2012 to 2017
The proportion of weight subgroups (%)
LBW 8949(8.7) 2723(8.6) 5226(8.8)
 VLBW 1693(1.8) 795(1.8) 898(1.8)
 MLBW 7145(7.6) 3291(7.6) 3854(7.6)
 Normal 82323(87.5) 37967(87.1) 44356(87.8)
 Macrosomia 2933(3.1) 1516(3.5) 1417(2.8)
Neonatal weight age ± SD, grams
 VLBW 1184 ± 201 1177 ± 200 1212 ± 316
 MLBW 2142 ± 267 2116 ± 263 2166 ± 271
 Normal 3182 ± 342 3166 ± 345 3194 ± 340
 Macrosomia 4198 ± 447 4194 ± 336 4184 ± 194
Table 2. The proportion and mean neonatal weight of weight subgroups.
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macrosomia using a logistic regression model. The proportion of VLBW monotone decreased from the years 
2005 to 2017, at an annual 1.0% of decline. However, the proportion of MLBW first increased and then declined 
during the same period, which resulted in a slight increase in the incidence of total LBW from 7.7% to 8.1% 
between 2005 and 2017. A national survey showed infants with birth weights less than 1500 g (VLBW) accounted 
for 3.8% in 1998, in the major cities of China21, which was almost twice that of our study (1.8%), and the incidence 
of LBW infants has been between 3.3% and 4.9% in Beijing urban area in the past 20 years5, which was slightly 
lower than reported in our study. On one hand, this reduction reflects dramatic advances in medical technology 
and continuously improved expectant management for LBW births over the past 20 years in China. On the other 
hand, differences in case definition between studies, regions and nations, and the institution based tertiary care 
settings of many previous studies may also have played a role in the observed reduced incidence. According to 
World Health Organization public data22, the incidence rates of LBW infants in major western countries respec-
tively were as follows: Australia (7%), Canada (6%), Germany (7%), France (7%) and US (8%) respectively, which 
were similar or slightly lower to our results. Furthermore, our data showed that more than 70.1% of the low birth 
weight infants were preterm births, which were similar to previous studies in Beijing5. We consider the main rea-
son for this pattern was due to the increasing survival rates of preterm births and the extremely LBW newborns 
in China; therefore, it is reasonable to assume that preterm birth was the primary cause of LBW in our study. In 
addition, this hospital is an emergency care center for the emergency care of critically ill mothers and newborns in 
the city. Full term LBW infants should also deserve public attention, because these babies or their mothers maybe 
more likely to develop severe complications or have a worse outcome.
Epidemiological studies show that a 1000 g reduction in birth weight results in a 1.7 fold increase in the risk of 
proteinuria in children, and a 3-fold increased risk of proteinuria in adulthood23. Other studies2,7 have shown that 
LBW infants have an increased risk of hypertension, kidney disease, type 2 diabetes, obesity, and coronary heart 
disease; however, the etiology for these complications remains unclear. LBW infants include infants who are small 
for their gestational age and with fetal growth restriction (FGR). A premature infant (<37 weeks of gestation) 
generally has an LBW, which might otherwise have been an appropriate weight if growth had continued normally 
until fullterm, but could also be a result of FGR. FGR is not an indication for a caesarean section, but FGR infants 
are likely to suffer from hypoxia and are not responsive to contractions. Thus, it is necessary to select the appro-
priate time for caesarean section as required, in FGR infants and identify potential risk factors to facilitate early 
intervention. Antepartum electronic fetal heart monitoring could be used closely during labor, and the delivery 
mode should be determined according to amniotic fluid volume and the duration of labor.
The prevalence of macrosomia was relatively muted, varying from 4.0% to 2.5%, and the downward trend is 
consistent with previous reports in China24, but the incidence was lower than in the northern part of China5. It 
has been reported that, since 2000, the incidence of macrosomia has been increasing across the United States and 
in other developed countries25,26. From the results of this study, although the proportion of pregnant women with 
an increased nutritional intake ratio has increased along with the improvement in the economy, the incidence of 
macrosomia showed a downward trend. This steady downward decline occurred later in Foshan, which may be 
Figure 2. Mean number and 95% CI by birth weight subgroups in Foshan during 2005 to 2017.
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explained through increased medical and health awareness and improved nutrition, education supervision and 
advice for all pregnant women, encouraging them to control their weight to within an acceptable range. Foshan is 
an economically developed city with low infant mortality rates, and the debate about whether caesarean section 
is needed for macrosomia has focused mainly on avoiding serious consequences such as shoulder dystocia, cla-
vicular fractures, possible postpartum hemorrhage, and brachial nerve injuries. Obstructed labor has resulted in 
notable adverse outcomes for mothers and infants in developing countries27, and cephalopelvic disproportion due 
to macrosomia is one of the most important outcomes28. However, aprenatal diagnosis of suspected macrosomia 
is challenging. Therefore, it remains controversial whether to perform a caesarean section in cases of suspected 
macrosomia. For a pregnant woman with an underlying disease, or with a small pelvis or who is malnourished, a 
caesarean section should be performed to prevent serious consequences, as fetal macrosomia is a major risk factor 
for infant morbidity and mortality.
Our findings showed that HDCP were strong risk factors associated with LBW, which is consistent with sev-
eral other studies29. This should alert gynecologists to be attentive to an early diagnosis of preeclampsia and 
eclampsia, which involve the two serious phases of HDCP, through testing mean arterial pressure, undertaking 
the roll-over test or hematological examinations. Although no consensus on macrosomia standards have been 
reached, there is evidence that the risk of adverse neonatal outcomes increases when the birth weight is 4000 g 
or greater30. As such, in this study of Asian women, a cut-off point of 4000 g seemed appropriate. In our study, 
being pregnant with diabetes, older gestational age and maternal age, high parity, and obesity were risk factors 
strongly associated with macrosomia. With an ageing population and an increasing maternal age following the 
introduction of the universal two-child policy in China, in addition to growing numbers of people with diabetes 
and obesity, macrosomia will continue to be an important public health issue in the future.
Electronic health records (EHRs) are an increasingly utilized resource for clinical and public health research, 
but there are several potential limitations with this study. First, despite this hospital being the largest maternity 
and child health care hospital in Foshan, with a stable number of more than 13000 deliveries per year, Berkson’s 
bias is likely, due to this being a single-center study. Therefore, the results might not be generalizable to other cities 
or countries discussed in this study. Additionally, the hospital’s electronic information system has been upgraded 
several times between 2005 and 2017, and may have an approximate 5% error rate, with some values missing 
from previous information. In the data cleaning and analysis phase, we corrected some of the obvious errors and 
either completed or deleted the missing values, which reduced errors to a minimum. Furthermore, our electronic 
Figure 3. Relative risk for birth weight subgroup in Foshan during 2005 to 2017. 2005 is the reference year 
(RR = 1.0), adjusted for maternal age, parity and gestational age, mode of delivery, HDCP, diabetes, and 
maternal BMI.
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information system does not provide information about gestational weight gain, which has been associated with 
macrosomia in previous studies19, and this may have resulted in biased estimates. Finally, this paper takes LBW 
as the research object, rather than the concepts of “small for gestational age” and “intrauterine growth restriction” 
which were commonly used by obstetrician. All these potential limitations should be considered when interpret-
ing the results of this study.
Conclusion
Constant urbanization and increasing growth in the national economy, coupled with the lifting of the one-child 
policy in China, means that the risk factors for LBW and macrosomia, such as hypertension, diabetes, obesity, and 
an older maternal age of childbearing women, will continue to increase rapidly. Thus, despite the relevant figures 
having declined slightly in our study, LBW and macrosomia will continue to be a major public health issue. More 
research aimed at controlling and preventing LBW and macrosomia risk factors and the detrimental outcomes in 
mothers and perinatal children is needed in China.
Methods
Study Population. The city of Foshan, located in South China, is the one of the largest city with a population 
of nearly 7.4 million of China. The entire study population consisted of 102,526 individuals at least 20 weeks ges-
tation from Southern Medical University Affiliated Maternal & Child Health Hospital of Foshan city, Guangdong 
province, China between January 2005 and March 2017. All mothers who had singleton births at the hospitals 
during this period were put into analysis. There were totally 109,780 live births in our study sites. The study 
excluded 4.708 births with missing birth weight, or newborns outside the range of 20–44 weeks, 2,500 cases of 
multiple pregnancies, and 46 cases with incredible weight range. Finally, a total of 102,526 cases were included in 
the study. This hospital was a tertiary university-affiliated medical center with a stable number of approximately 
10,000 to 13,000 deliveries per year, which is accounting for 1/8 of total number of newborns in Foshan city. An 
informed consent was obtained from all participants. In order to ensure patient privacy, our data did not include 
the patient’s name, phone number, home address, or other sensitive information.
The study was approved by the Human Subjects Committee of the Southern Medical University Affiliated 
Maternal & Child Health Hospital of Foshan and all methods were performed in accordance with the relevant 
guidelines and regulations30.
Risk Fators
LBW Macrosomia
RR (95% CI) p-Value RR (95% CI) p-Value
Sex
 Girls (Ref) 1 1
 Boys 1.17(1.08 to 1.26) <0.001 1.91(1.71 to 2.14) <0.001
Maternal age, n (%)
 <20 y (Ref) 1 1
 20–24 y 2.05(1.57 to 2.67) <0.001 1.19(0.60 to 2.32)
 25–29 y 2.78(2.14 to 3.61) <0.001 1.71(0.88 to 3.33)
 30–34 y 2.63(2.01 to 3.45) <0.001 2.29(1.17 to 4.47) <0.001
 >35 y 1.85(1.39 to 2.46) <0.001 2.44(1.23 to 4.82) <0.001
Parity
 0 (Ref) 1 1
 1 0.92(0.84 to 1.01) 0.093 1.77(1.59 to 1.98) <0.001
 ≥2 0.70(0.57 to 0.85) <0.001 2.28(1.74 to 2.98) <0.001
Gestational age
 <37 wk (Ref) 1 1
 37 to 41 wk 0.04(0.03 to 0.04) <0.001 6.64(5.21 to 8.44) <0.001
 ≥42 wk 0.04(0.01 to 0.38) 0.004 20.45(7.63 to 54.78) <0.001
HDCP
 No (Ref) 1 1
 yes 5.92(5.35 to 6.55) <0.001 1.31 (1.02 to 1.68) 0.034
Diabetes
 No (Ref) 1 1
 Yes 1.38 (1.26 to 1.50) <0.001 1.58 (1.36 to 1.83) <0.001
BMI
 <25 (Ref) 1 1
 25 to 30 0.56(0.51 to 0.62) <0.001 3.22(2.69 to 3.84) <0.001
 ≥30 0.68(0.58 to 0.82) <0.001 9.62(7.91 to 11.72) <0.001
Table 3. Multiple logistic regression analyses of factors associated with LBW and Macrosomia. Adjusted for 
nationality, mode of delivery.
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Definition of Variables and Data Extraction. Refered to the standard of the WHO, low birth weight 
(LBW) is defined as birth weight less than 2500 grams, and subdivided further into very low birth weight (VLBW, 
<1500 g) and moderately low birth weight (MLBW, 1500 to 2499 g). Macrosomia is defined as birth weight more 
than 4000 grams. The major covariates studied included the following characteristics of the mother: infant sex 
[male, female], age [less than 20, 20 to 24, 25 to 30, 30 or more years], mode of delivery [vaginal birth, cesarean 
section], parity [one, two, three or more], gestational age [<37weeks, ≥37weeks], hypertensive disorder com-
plicating pregnancy(HDCP) or not, diabetes mellitus or not, body mass index (BMI) [<25, 25 to 30, ≥30]. We 
calculated gestational age on the basis of the actual delivery date in the medical record. HDCP (systolic blood 
pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg, with or without proteinuria) can be classified 
into five groups: (1)gestational hypertension, (2)preeclampsia, (3)eclampsia, (4)superimposed preeclampsia on 
chronic hypertension and (5) chronic hypertension in pregnancy31,32. Diabetes including diabetes mellitus (DM) 
and gestational diabetes mellitus (GDM). Diagnostic criteria with reference to the recommendation from the 
Chinese Medical Association Obstetrics Group33. GDM was diagnosed when one of the following condition was 
met: (1) fasting plasma glucose ≥5.8 mmol /L twice or more times; (2) two or more test results are equal or above 
the following values after a 100 g-load OGTT: fasting, 5.8 mmol/L; 1-hour, 10.6 mmol/L; 2-hour, 9.2 mmol/L; 
3-hour, 8.6 mmol/L; (3) 50 g glucose challenge test ≥11.1 mmol/L and fasting plasma glucose ≥5.8 mmol/L. All 
diagnosis of HDCP and diabetes was confirmed by obstetricians or specialist physician. Body mass index (BMI) 
was calculated from height and weight before delivery (BMI = weight in kg/height2 in meter). To ensure the reli-
ability of data, systematic training was provided for data entry operator for understanding of the study objective 
and methods.
Statistical analysis. For descriptive analysis, mean and SD were calculated for continuous variables, and 
percentages for categorical variables. Birth weight was analyzed by categorizing into four outcome variables: 
VLBW (<1500 g), MLBW (1500 to 2499 g), normal birth weight (2500 to 4000 g) and macrosomia (≥4000 g). 
Trend analysis were quantified using the Join point Regression Program (National Cancer Institute), version 
4.4.0.0, which uses permutation analysis to fit a series of straight lines on a logarithmic scale to observed rates to 
estimate annual percent change (APC), resulting in trends of variable length. The Annual Percent Change (APC) 
is significantly different from zero at the alpha = 0.05 level. Binary logistic regression was used to estimate the 
relative risk (RR) and corresponding 95% confidence interval (CI) of the association between low birth weight 
and macrosomia. We mutually adjusted the analysis of the risk factors for LBW and macrosomia for infant sex, 
maternal age, parity, mode of delivery, gestational age, HDCP, diabetes, body mass index (BMI) in the model. The 
variables were considered based on literature review for their relevance to LBW and macrosomia and availability 
of data. p-Values of two-sided tests, 0.05 were considered statistically. All analyses were performed with R for 
Windows version 3.4.1.
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